Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson’s Disease

Motor and cognitive functions depend on the coordinated interactions between dopamine (DA) and acetylcholine (ACh) at striatal synapses. Increased ACh availability was assumed to accompany DA deficiency based on the outcome of pharmacological treatments and measurements in animals that were critically depleted of DA. Using Slc6a3DTR/+ diphtheria-toxin-sensitive mice, we demonstrate that a progressive and L-dopa-responsive DA deficiency reduces ACh availability and the transcription of hyperpolarization-activated cation (HCN) channels that encode the spike timing of ACh-releasing tonically active striatal interneurons (ChIs). Although the production and release of ACh and DA are reduced, the preponderance of ACh over DA contributes to the motor deficit. The increase in striatal ACh relative to DA is heightened via D1-type DA receptors that activate ChIs in response to DA release from residual axons. These results suggest that stabilizing the expression of HCN channels may improve ACh-DA reciprocity and motor function in Parkinson's disease (PD). VIDEO ABSTRACT.

[1]  R. Palmiter,et al.  Acetylcholine Encodes Long-Lasting Presynaptic Plasticity at Glutamatergic Synapses in the Dorsal Striatum after Repeated Amphetamine Exposure , 2013, The Journal of Neuroscience.

[2]  Yvette E. Fisher,et al.  Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease,, , 2015, eNeuro.

[3]  S. Stoll,et al.  Mechanism for the inhibition of the cAMP dependence of HCN ion channels by the auxiliary subunit TRIP8b , 2017, The Journal of Biological Chemistry.

[4]  Charles J. Wilson,et al.  Intrinsic Membrane Properties Underlying Spontaneous Tonic Firing in Neostriatal Cholinergic Interneurons , 2000, The Journal of Neuroscience.

[5]  Pavel Osten,et al.  HCN Channelopathy in External Globus Pallidus Neurons in Models of Parkinson’s Disease , 2010, Nature Neuroscience.

[6]  R. Palmiter,et al.  Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment , 2015, Experimental Neurology.

[7]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[8]  J. Paul Bolam,et al.  Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis , 2016, Front. Neuroanat..

[9]  A M Graybiel,et al.  The basal ganglia and adaptive motor control. , 1994, Science.

[10]  N. Cheviron,et al.  Exploring the Regulation of the Expression of ChAT and VAChT Genes in NG108-15 Cells: Implication of PKA and PI3K Signaling Pathways , 2003, Neurochemical Research.

[11]  O. Hornykiewicz,et al.  Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat , 1992, Brain Research.

[12]  Charles J. Wilson,et al.  Spontaneous Activity of Neostriatal Cholinergic Interneurons In Vitro , 1999, The Journal of Neuroscience.

[13]  R. Palmiter,et al.  Dopamine Modulates Release from Corticostriatal Terminals , 2004, The Journal of Neuroscience.

[14]  F. Horak,et al.  Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease , 2010, Neurology.

[15]  R. Wightman,et al.  Dopamine’s Effects on Corticostriatal Synapses during Reward-Based Behaviors , 2018, Neuron.

[16]  N. Bamford,et al.  Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core , 2012, The Journal of physiology.

[17]  A. Graybiel,et al.  Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. , 1994, Science.

[18]  J. Caviness Pathophysiology of Parkinson's disease behavior--a view from the network. , 2014, Parkinsonism & related disorders.

[19]  P. Garris,et al.  ‘Passive stabilization’ of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6‐OHDA‐lesioned rat , 2003, Journal of neurochemistry.

[20]  Stefan Stoll,et al.  Double electron–electron resonance reveals cAMP-induced conformational change in HCN channels , 2014, Proceedings of the National Academy of Sciences.

[21]  R. Albin,et al.  The cholinergic system and Parkinson disease , 2011, Behavioural Brain Research.

[22]  Y. Kawaguchi,et al.  Dopamine D1-Like Receptor Activation Excites Rat Striatal Large Aspiny Neurons In Vitro , 1998, The Journal of Neuroscience.

[23]  C. Konradi,et al.  Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia , 2004, Neurobiology of Disease.

[24]  M Abeles,et al.  Activity of Pallidal and Striatal Tonically Active Neurons Is Correlated in MPTP-Treated Monkeys But Not in Normal Monkeys , 2001, The Journal of Neuroscience.

[25]  J. Lechleiter,et al.  Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease , 2016, The Journal of Neuroscience.

[26]  M. Zigmond,et al.  Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  Xiaoli Wei,et al.  Involvement of HCN Channel in Muscarinic Inhibitory Action on Tonic Firing of Dorsolateral Striatal Cholinergic Interneurons , 2016, Front. Cell. Neurosci..

[28]  J. Wickens,et al.  Pauses in cholinergic interneuron firing exert an inhibitory control on striatal output in vivo , 2018, eLife.

[29]  C. Cepeda,et al.  Repeated Exposure to Methamphetamine Causes Long-Lasting Presynaptic Corticostriatal Depression that Is Renormalized with Drug Readministration , 2008, Neuron.

[30]  A. Beley,et al.  Brain fixation for acetylcholine measurements , 1994, Journal of Neuroscience Methods.

[31]  J. Lehmann,et al.  The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals? , 1983, Neuroscience.

[32]  R. Palmiter,et al.  Loss of glutamate signaling from the thalamus to dorsal striatum impairs motor function and slows the execution of learned behaviors , 2018, npj Parkinson's Disease.

[33]  H. Lindgren,et al.  A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function , 2004, Neurobiology of Disease.

[34]  E. Abercrombie,et al.  Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats , 1990, Brain Research.

[35]  A. Colino,et al.  ZD 7288 inhibits T-type calcium current in rat hippocampal pyramidal cells , 2008, Neuroscience Letters.

[36]  Nicolas Maurice,et al.  D2 Dopamine Receptor-Mediated Modulation of Voltage-Dependent Na+ Channels Reduces Autonomous Activity in Striatal Cholinergic Interneurons , 2004, The Journal of Neuroscience.

[37]  Hui Zhang,et al.  Heterosynaptic Dopamine Neurotransmission Selects Sets of Corticostriatal Terminals , 2004, Neuron.

[38]  P Riederer,et al.  Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. , 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[39]  P. Garris,et al.  Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals , 1997, Brain Research.

[40]  E. Vaadia,et al.  Coincident but Distinct Messages of Midbrain Dopamine and Striatal Tonically Active Neurons , 2004, Neuron.

[41]  R. Spehlmann,et al.  DOPAMINE ACETYLCHOLINE IMBALANCE IN PARKINSON'S DISEASE Possible Regenerative Overgrowth of Cholinergic Axon Terminals , 1976, The Lancet.

[42]  S. A. O. Lim,et al.  Enhanced striatal cholinergic neuronal activity mediates l-DOPA–induced dyskinesia in parkinsonian mice , 2010, Proceedings of the National Academy of Sciences.

[43]  Antonio Pisani,et al.  Acetylcholine-mediated modulation of striatal function , 2000, Trends in Neurosciences.

[44]  Taro Kiritani,et al.  Corticospinal-specific HCN expression in mouse motor cortex: I(h)-dependent synaptic integration as a candidate microcircuit mechanism involved in motor control. , 2011, Journal of neurophysiology.

[45]  R. Burke,et al.  Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.

[46]  Charles J. Wilson,et al.  The Cholinergic Interneurons of the Striatum: Intrinsic Properties Underlie Multiple Discharge Patterns , 2010 .

[47]  J. Jankovic Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[48]  R. Palmiter,et al.  Cell-type-specific isolation of ribosome-associated mRNA from complex tissues , 2009, Proceedings of the National Academy of Sciences.

[49]  C. Clarke,et al.  MEDICAL MANAGEMENT OF PARKINSON'S DISEASE , 2002, Journal of neurology, neurosurgery, and psychiatry.

[50]  H. Yonekawa,et al.  Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice , 2001, Nature Biotechnology.

[51]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[52]  R. Palmiter,et al.  Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease , 2014, Neurobiology of Disease.

[53]  Xing Wu,et al.  Is ZD7288 a selective blocker of hyperpolarization-activated cyclic nucleotide-gated channel currents? , 2012, Channels.

[54]  D. Mash,et al.  Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease , 2001 .

[55]  S. Siegelbaum,et al.  TRIP8b Regulates HCN1 Channel Trafficking and Gating through Two Distinct C-Terminal Interaction Sites , 2011, The Journal of Neuroscience.

[56]  M. Zigmond,et al.  Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. , 1984, Archives of neurology.

[57]  S. Siegelbaum,et al.  Molecular mechanism of cAMP modulation of HCN pacemaker channels , 2001, Nature.

[58]  G. Snyder,et al.  Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. , 1990, The Journal of pharmacology and experimental therapeutics.

[59]  N. Bamford,et al.  Nicotine Modifies Corticostriatal Plasticity and Amphetamine Rewarding Behaviors in Mice , 2016, eNeuro.

[60]  Daniel S. McGehee,et al.  Striatal cholinergic interneuron regulation and circuit effects , 2014, Front. Synaptic Neurosci..

[61]  A. Barbeau The pathogenesis of Parkinson's disease: a new hypothesis. , 1962, Canadian Medical Association journal.

[62]  D. Surmeier,et al.  D5 Dopamine Receptors Enhance Zn2+-Sensitive GABAA Currents in Striatal Cholinergic Interneurons through a PKA/PP1 Cascade , 1997, Neuron.

[63]  M. Zigmond,et al.  Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6‐Hydroxydopamine Administration: A Flow Cytometric Study , 1989, Journal of neurochemistry.

[64]  D. Haydon,et al.  Ion transfer across lipid membranes in the presence of gramicidin A. II. The ion selectivity. , 1972, Biochimica et biophysica acta.

[65]  S. Waxman Transcriptional channelopathies: An emerging class of disorders , 2001, Nature Reviews Neuroscience.

[66]  M. Albert,et al.  CSF cyclic nucleotides and somatostatin in Parkinson's disease , 1986, Neurology.

[67]  D. Sulzer,et al.  How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission , 2011, Neuron.

[68]  T. Deguchi,et al.  Transcriptional Regulation of Choline Acetyltransferase Gene by Cyclic AMP , 1993, Journal of neurochemistry.

[69]  N. Bamford,et al.  The Striatum’s Role in Executing Rational and Irrational Economic Behaviors , 2019, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[70]  E. Benarroch HCN channels , 2013, Neurology.

[71]  R. Burke Recent Advances in Research on Parkinson Disease: Synuclein and Parkin , 2004, The neurologist.

[72]  T. Slotkin,et al.  Effects of reserpine on the content and properties of rat adrenal medullary storage vesicles. , 1973, Biochemical pharmacology.

[73]  Ted M. Dawson,et al.  Genetic Animal Models of Parkinson's Disease , 2010, Neuron.